| Financial Year |
March 31 2023 |
| Monetary Funds |
3,571,532,389.09 |
| Held-for-trading Financial Assets |
1,234,308,622.82 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,285,324,434.99 |
| Advances to Suppliers |
149,597,966.95 |
| Other Receivables |
426,133,809.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,488,889,401.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
294,567,794.65 |
| Total Current Assets |
10,456,653,362.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,249,082.40 |
| Investment Properties |
-- |
| Fixed Assetes |
1,199,123,004.01 |
| Under-construction Projects |
285,138,303.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
471,776,808.07 |
| R&D expenses |
14,558,900.44 |
| Goodwill |
4,346,543,745.35 |
| Long-Term Deferred and Prepaid Expenses |
414,232,580.26 |
| Deferred Income Tax Assets |
132,947,417.06 |
| Other Non-Current Assets |
9,887,407.49 |
| Sub-Total of Non-Current Assets |
10,942,725,254.65 |
| Total Assets |
21,399,378,617.37 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,098,207,047.01 |
| Accounts Payable |
1,582,857,750.09 |
| Accounts Received In Advance |
7,910,895.41 |
| Employee Compensation Payable |
328,372,752.73 |
| Taxes Payable |
295,487,211.80 |
| Interest Payable |
-- |
| Dividend Payable |
7,707,033.01 |
| Other payables |
819,802,650.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,450,187,087.59 |
| Other Current Liabilities |
5,741,908.97 |
| Sub-Total of Current Liabilities |
9,635,983,335.72 |
| Long-term Loans |
152,367,316.34 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
47,178,744.93 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,138,076,842.24 |
| Total Liabilities |
11,774,060,177.95 |
| Paid-In Capital(Or Share Stock) |
721,704,930.00 |
| Capital Surplus |
4,090,373,261.91 |
| Surplus Reserve |
132,066,047.02 |
| LESS:Treasury Stock |
77,410,952.00 |
| Undistributed Profits |
4,056,497,305.48 |
| Minority Stockholder's Interest |
611,480,937.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,013,837,501.90 |
| Owner's Equity（Stockholder's Equity） |
9,625,318,439.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,399,378,617.37 |
